ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Immunometabolism of Regulatory T Cells Enhanced by Lipid Nanoparticles

J. S. Rink1, Y. Sambandam2, J. He2, J. Mathew3, J. R. Leventhal4, C. S. Thaxton5

1Department of Medicine, Division of Hematology/ Oncology, Northwestern University, Chicago, IL, 2Comprehensive Transplant Center, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4Surgery, Northwestern Medicine, Chicago, IL, 5Department of Urology, Northwestern University, Chicago, IL

Meeting: 2022 American Transplant Congress

Abstract number: 1262

Keywords: Bioengineering, Gene expression, Lipids, T cells

Topic: Basic Science » Basic Science » 10 - Treg/Other Regulatory Cell/Tolerance

Session Information

Session Name: Treg/Other Regulatory Cell/Tolerance

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Human regulatory T cell (Treg) metabolism is highly dependent upon a number of factors, including cholesterol obtained from circulating lipoproteins. We have developed high-density lipoproteins-like nanoparticles (HDL NPs), which mimic mature, cholesterol-rich HDLs, with the aim of improving ex vivo Treg cell expansion and survival.

*Methods: HDL-like nanoparticles (HDL NPs) were templated using either a gold (Au) nanoparticle core or a soft organic tetrahedral core (oc), and mimic the size, shape and surface composition of mature, spherical HDLs. HDL NPs specifically target the high affinity HDL receptor scavenger receptor type B1 (SR-B1). Treg cells were polyclonally expanded in the presence of Au- or oc-HDL NPs, or controls [PBS, reconstituted HDL (rHDL)] and assayed for proliferation (by cell counts), survival (by flow cytometry), expression of Treg markers, SR-B1 and cholesterol biosynthesis genes (by RT-qPCR and flow cytometry), and total cellular cholesterol levels (by Amplex Red cholesterol assay).

*Results: Culture of Tregs with Au and oc HDL NPs did not affect the markers of Treg such as CD3, CD4, CD25 and FoxP3 expression compared to PBS control. However, Au- and oc-HDL NPs significantly increased SR-B1 expression during the first 7 days of treatment. Further, Au-HDL NP treatment of Treg cells increased expression of cholesterol biosynthesis genes during the first 7 days of treatment, including among others HMG Co-A synthase 1 (1.00 ± 0.16 for PBS vs. 1.36 ± 0.09 for Au-HDL NP treated) and 7-dehydrocholesterol reductase (1.00 ± 0.09 vs. 1.21 ± 0.07), which was not seen with oc-HDL NPs and rHDL. Total cellular cholesterol content was not altered with Au- or oc-HDL NP treatment over a treatment period of 21 days. Treg proliferation increased with Au- (1.97) and oc-HDL NP (1.11) treatment, as well as rHDL (1.63), compared to PBS control (1.00), while having no adverse effects on viability.

*Conclusions: These results demonstrate that targeting SR-B1 with HDL-like nanoparticles can alter the immunometabolic state of Treg cells and promote proliferation during ex vivo expansion.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Rink JS, Sambandam Y, He J, Mathew J, Leventhal JR, Thaxton CS. Immunometabolism of Regulatory T Cells Enhanced by Lipid Nanoparticles [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/immunometabolism-of-regulatory-t-cells-enhanced-by-lipid-nanoparticles/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences